ArticleThe American journal of geriatric pharmacotherapy2011

Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes ≥65 and <65 years of age: a pooled analysis from phase III studies.

Bruce W Bode et al.PubMed ↗Publisher ↗

No numbers read from the abstract.